Sone Capital Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.64M Buy
39,340
+11,222
+40% +$1.57M 0.39% 70
2025
Q4
$4.61M Sell
28,118
-110,417
-80% -$17.3M 0.37% 79
2025
Q3
$18.5M Buy
138,535
+68,083
+97% +$8.27M 1.55% 20
2025
Q2
$8.76M Buy
70,452
+40,719
+137% +$5.18M 0.81% 54
2025
Q1
$3.78M Buy
+29,733
New +$4.58M 0.39% 80

Other funds holding RGEN

Sone Capital Management's RGEN Position: Q1 2026 in Review

Sone Capital Management increased its Repligen (RGEN) stake by 40% in Q1 2026, buying an estimated $1.57M and bringing the position to 39,340 shares worth $4.64M. The position accounts for 0.39% of the portfolio, ranked #70.

Sone Capital Management first reported a position in RGEN in Q1 2025 and has held it in 5 quarters since. The position peaked at $18.5M in Q3 2025. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Sone Capital Management held 39,340 shares of Repligen worth $4.64M as of Q1 2026.
  • Sone Capital Management bought 11,222 Repligen shares in Q1 2026, an estimated $1.57M.
  • Repligen made up 0.39% of Sone Capital Management's portfolio in Q1 2026, its #70 holding.
  • Sone Capital Management first reported a position in Repligen in Q1 2025 and has held it in 5 quarters since.
  • Sone Capital Management's Repligen position peaked at $18.5M in Q3 2025.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Sone Capital Management's 13F filing for Q1 2026, filed 15 May 2026.